Cargando…
Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia
A 70-year-old end-stage renal disease patient was admitted for refractory hypoglycemia secondary to drug-drug interaction between clarithromycin and glipizide. We discussed the mechanism of antimicrobial and sulfonylurea interactions as well as the importance of understanding these interactions in t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679710/ https://www.ncbi.nlm.nih.gov/pubmed/31396468 http://dx.doi.org/10.7759/cureus.4800 |
_version_ | 1783441393272750080 |
---|---|
author | Ruan, Xu Cong Tan, Poh Yong Tan, Yuyang |
author_facet | Ruan, Xu Cong Tan, Poh Yong Tan, Yuyang |
author_sort | Ruan, Xu Cong |
collection | PubMed |
description | A 70-year-old end-stage renal disease patient was admitted for refractory hypoglycemia secondary to drug-drug interaction between clarithromycin and glipizide. We discussed the mechanism of antimicrobial and sulfonylurea interactions as well as the importance of understanding these interactions in the primary care setting to reduce medication-related hospitalizations. |
format | Online Article Text |
id | pubmed-6679710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-66797102019-08-08 Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia Ruan, Xu Cong Tan, Poh Yong Tan, Yuyang Cureus Endocrinology/Diabetes/Metabolism A 70-year-old end-stage renal disease patient was admitted for refractory hypoglycemia secondary to drug-drug interaction between clarithromycin and glipizide. We discussed the mechanism of antimicrobial and sulfonylurea interactions as well as the importance of understanding these interactions in the primary care setting to reduce medication-related hospitalizations. Cureus 2019-06-02 /pmc/articles/PMC6679710/ /pubmed/31396468 http://dx.doi.org/10.7759/cureus.4800 Text en Copyright © 2019, Ruan et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Ruan, Xu Cong Tan, Poh Yong Tan, Yuyang Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia |
title | Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia |
title_full | Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia |
title_fullStr | Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia |
title_full_unstemmed | Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia |
title_short | Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia |
title_sort | clarithromycin and glipizide drug-drug interaction leading to refractory hypoglycemia |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679710/ https://www.ncbi.nlm.nih.gov/pubmed/31396468 http://dx.doi.org/10.7759/cureus.4800 |
work_keys_str_mv | AT ruanxucong clarithromycinandglipizidedrugdruginteractionleadingtorefractoryhypoglycemia AT tanpohyong clarithromycinandglipizidedrugdruginteractionleadingtorefractoryhypoglycemia AT tanyuyang clarithromycinandglipizidedrugdruginteractionleadingtorefractoryhypoglycemia |